GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Fundamental Analysis & Valuation

EBR:GBLB • BE0003797140

Current stock price

77.75 EUR
+0.75 (+0.97%)
Last:

This GBLB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GBLB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year GBLB has reported negative net income.
  • The reported net income has been mixed in the past 5 years: GBLB reported negative net income in multiple years.
  • GBLB had a positive operating cash flow in 4 of the past 5 years.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.45%, GBLB is doing worse than 71.43% of the companies in the same industry.
  • GBLB's Return On Equity of -5.06% is on the low side compared to the rest of the industry. GBLB is outperformed by 66.07% of its industry peers.
  • GBLB has a Return On Invested Capital of 1.19%. This is comparable to the rest of the industry: GBLB outperforms 44.64% of its industry peers.
Industry RankSector Rank
ROA -2.45%
ROE -5.06%
ROIC 1.19%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Operating Margin of GBLB (5.65%) is comparable to the rest of the industry.
  • GBLB's Operating Margin has declined in the last couple of years.
  • GBLB has a Gross Margin of 69.88%. This is in the better half of the industry: GBLB outperforms 67.86% of its industry peers.
  • In the last couple of years the Gross Margin of GBLB has remained more or less at the same level.
Industry RankSector Rank
OM 5.65%
PM (TTM) N/A
GM 69.88%
OM growth 3Y83.31%
OM growth 5Y-16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.14%
GM growth 5Y-0.72%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

3

2. GBLB.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBLB is destroying value.
  • There is no outstanding debt for GBLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.31, we must say that GBLB is in the distress zone and has some risk of bankruptcy.
  • GBLB has a Altman-Z score (1.31) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.51 indicates that GBLB is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GBLB (0.51) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.18
WACC6.6%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.91 indicates that GBLB should not have too much problems paying its short term obligations.
  • GBLB has a better Current ratio (1.91) than 73.21% of its industry peers.
  • A Quick Ratio of 1.56 indicates that GBLB should not have too much problems paying its short term obligations.
  • The Quick ratio of GBLB (1.56) is better than 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.56
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1

3. GBLB.BR Growth Analysis

3.1 Past

  • GBLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -614.58%.
  • GBLB shows a decrease in Revenue. In the last year, the revenue decreased by -5.30%.
  • GBLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.97% yearly.
EPS 1Y (TTM)-614.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-356.14%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y4.99%
Revenue growth 5Y-0.97%
Sales Q2Q%100.15%

3.2 Future

  • Based on estimates for the next years, GBLB will show a decrease in Earnings Per Share. The EPS will decrease by -0.75% on average per year.
  • Based on estimates for the next years, GBLB will show a small growth in Revenue. The Revenue will grow by 4.54% on average per year.
EPS Next Y-20.1%
EPS Next 2Y-0.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.36%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

0

4. GBLB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • GBLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • GBLB is valuated quite expensively with a Price/Forward Earnings ratio of 27.71.
  • 64.29% of the companies in the same industry are cheaper than GBLB, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.61. GBLB is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 27.71
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.75%
EPS Next 3YN/A

5

5. GBLB.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.68%, GBLB is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.54, GBLB pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.68%

5.2 History

  • The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-0.75%
EPS Next 3YN/A
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

GBLB.BR Fundamentals: All Metrics, Ratios and Statistics

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (3/31/2026, 7:00:00 PM)

77.75

+0.75 (+0.97%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners25%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap10.36B
Revenue(TTM)6.33B
Net Income(TTM)-625.40M
Analysts84.29
Price Target87.85 (12.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.68%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP0%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.01%
PT rev (3m)3.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-19.1%
EPS NY rev (3m)-19.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.71
P/S 1.64
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-4.94
EYN/A
EPS(NY)2.81
Fwd EY3.61%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS47.53
BVpS92.77
TBVpS39.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.45%
ROE -5.06%
ROCE 1.59%
ROIC 1.19%
ROICexc 1.4%
ROICexgc 2.22%
OM 5.65%
PM (TTM) N/A
GM 69.88%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y83.31%
OM growth 5Y-16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.14%
GM growth 5Y-0.72%
F-ScoreN/A
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.56
Altman-Z 1.31
F-ScoreN/A
WACC6.6%
ROIC/WACC0.18
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-614.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-356.14%
EPS Next Y-20.1%
EPS Next 2Y-0.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y4.99%
Revenue growth 5Y-0.97%
Sales Q2Q%100.15%
Revenue Next Year4.36%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.59%
EBIT growth 3Y92.45%
EBIT growth 5Y-16.82%
EBIT Next Year312.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

GROUPE BRUXELLES LAMBERT NV / GBLB.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GBLB.BR.


Can you provide the valuation status for GROUPE BRUXELLES LAMBERT NV?

ChartMill assigns a valuation rating of 0 / 10 to GROUPE BRUXELLES LAMBERT NV (GBLB.BR). This can be considered as Overvalued.


How profitable is GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) has a profitability rating of 2 / 10.


How financially healthy is GROUPE BRUXELLES LAMBERT NV?

The financial health rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 3 / 10.